Helius Medical raised $2 million in a new round of financing, looking to reel in another $10.3 million to bring its total up to $12.3 million for the round. Newtown, Penn.-based Helius Medical did not release any information on what the funds will be used for. The $2 million in funds already raised come from 1 […]
Baxter (NYSE:BAX) said today that it named Boston Scientific (NYSE:BSX) CEO Mike Mahoney to its board of directors. Mahoney, who engineered a significant turnaround at Boston Scientific, was tapped to serve on Baxter’s governance and compensation committees. “Mike’s significant knowledge of the global medical products business and his track record of leadership will make a significant contribution […]
Helius Medical said today it signed a $7 million strategic agreement with A&B Company Limited to develop and commercialize Helius’ Portable Neuromodulation Stimulator in China, Hong Kong, Macao, Taiwan and Singapore. With the agreement, A&B will provide Helius with a $7 million credit facility, with $2 million drawn down and convertible promissory notes issued, the company […]
Helius Medical said today it and the U.S. Army Medical Research and Material Command have launched a phase 3 clinical trial of Helius’ portable neuromodulation stimulator. The PoNS unit is designed to treat balance disorder in patients with mild-to-moderate traumatic brain injury, the Newtown, Pa.-based company said. “Together with our partners at the USAMRMC, we […]
Helius Medical Technologies said yesterday its subsidiary NeuroHabilitation Corporation inked a cost sharing contract with the U.S. Army Medical Research and Materiel Command to support a trial of its portable neuromodulation stimulator. The device is designed to treat balance disorder in patients with mild to moderate traumatic brain injury, the Newton, Penn.-based company said. “This important contract represents […]
Starting a medtech company comes with a host of challenges, from regulation to financing to reimbursement. One way that companies can overcome those challenges, according to 2 industry experts, is to outsource some of the research and development work – and in the process, create a leaner, more flexible company.
The FDA gave the green light for Helius Medical Technologies to begin enrolling patients in a clinical trial of its portable neuromodulation stimulator in patients with chronic balance disorders due to mild-to-moderate brain injury.